At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance (AMR). As the landscape of innovation and funding continues to evolve, so must we. Recognizing the increasing importance of strategic [...]
More news
The first Entrepreneurs Club is on July 7th 5-6pm CEST. Magdalena Kempa, CEO Smartbax and [...]
Congratulations to LimmaTech Biologics AG for the AMR Conference prize We are very happy to [...]
The INCATE portfolio is now live at Portfolio More than a million people die because [...]
INCATE is supporting a startup competition at the AMRCONFERNCE on April 7th. You will have [...]
We will be joining the hunt for next generation antimicrobial agents December 9-10 in a [...]
We were delighted to present at this event sharing advances in the science and funding [...]
INCATE was part of a Panel on Financing Innovation at the AMR Conference on August [...]
